By Shawn H.E. Harmon
The
possibility of improving outcomes and cost-effectiveness by tailoring therapies
to patients’ genetic profiles (stratified medicine) is a dream of researchers
and healthcare programmes, although at present relatively few tests are viewed
as reliable.[1]
Counterbalancing these positives, genetic information can also be used to discriminate against individuals; information about otherwise healthy people’s predisposition can affect how decisions are made in relation to a wide range of fields, including insurance (coverage, premiums, deductibles), employment (hiring, promotion, dismissal), banking (loans), education (funding, acceptance), sports (participation), and more, and has already affected people in relation to employment and insurance.[2]
Counterbalancing these positives, genetic information can also be used to discriminate against individuals; information about otherwise healthy people’s predisposition can affect how decisions are made in relation to a wide range of fields, including insurance (coverage, premiums, deductibles), employment (hiring, promotion, dismissal), banking (loans), education (funding, acceptance), sports (participation), and more, and has already affected people in relation to employment and insurance.[2]
